Genentech, Inc. (NYSE:DNA), GlycArt, a company wholly-owned by Roche, and Roche (SWX:ROG) have entered into a collaboration agreement, including a license from GlycArt to Genentech, for the joint development and commercialization of GlycArt’s GA101 molecule.

As part of a comprehensive R&D effort to develop an analytic tool to assist in accurately identifying leukemia stem cells, Oerlikon Leybold Vacuum is supporting the StemSpec R&D project at the University of Toronto with a TURBOVAC SL turbomolecular vacuum pump and a fore vacuum pump, and advising researchers about the use of the pumps.

The International Myeloma Foundation (IMF) – supporting research and providing education, advocacy, and support for myeloma patients, families, researchers, and physicians – today heralded the expansion of treatment options for previously untreated patients with multiple myeloma, giving patients in Canada and Europe access to drugs similar to what is available to patients in the United States.

The British Lymphology Society (BLS), the only UK body representing the medical professionals who treat lymphoedema, has chosen Belfast as the venue for its high profile annual conference. Nearly 200 nursing and physiotherapy delegates, plus 11 pharmaceutical companies will be gathering at the Wellington Park Hotel for three days; 5-7 October.

Virginia Commonwealth University Institute of Molecular Medicine and VCU Massey Cancer Center researchers have discovered how a gene, melanoma differentiation associated gene-9/syntenin (mda-9/syntenin), interacts with an important signaling protein to promote metastasis in human melanoma cells, a discovery that could one day lead to the development of the next generation of anti-metastatic drugs for melanoma and other cancers.

Sports personality Gary Lineker visited the Royal Free Hospital in London on 24th September to meet the country’s first Leukaemia CARE Clinical Nurse Specialist. Clara Patmore, who started in her new role at the Hampstead hospital this summer, is the first nurse in the UK to be funded by the charity Leukaemia CARE.

Know Your Nodes! That’s the message the lymphoma Association and Leukaemia CARE are spreading ahead of World lymphoma Awareness Day (WLAD), an event held annually on September 15th which aims to inform the public about lymphoma; the sixth most common cancer in the UK.

New research has revealed we are more concerned about cancer now than we were 10 years ago – even though we know the outlook for anyone diagnosed with cancer today is more positive than ever1.

A Macmillan Clinical Nurse Specialist in Haemato-Oncology has won an award for her ‘Outstanding Contribution in Care and Support.’ Debbie Gardiner, who works at St George’s Hospital in London, received the lymphoma Association’s Beacon of Hope Award, where she was recognized for her dedication to patients and her hard work in setting up a local support group.